GeneDx Holdings (WGS) Current Assets (2020 - 2026)

GeneDx Holdings (WGS) has reported Current Assets for 7 consecutive years, with $270.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Current Assets rose 19.84% year-over-year to $270.6 million; the TTM figure through Mar 2026 stood at $270.6 million (up 19.84% YoY), while the FY2025 annual figure was $268.3 million, up 35.52% from the prior year.
• Current Assets grew to $270.6 million in Q1 2026 per WGS's latest filing, from $268.3 million in the prior quarter.
• Across five years, Current Assets topped out at $410.4 million in Q1 2022 and bottomed at $162.2 million in Q2 2024.
• Historically, Current Assets has averaged $240.5 million across 5 years, with a median of $213.3 million in 2023.
• On a YoY basis, Current Assets climbed as much as 306.72% in 2022 and fell as far as 56.03% in 2022.
• GeneDx Holdings' Current Assets stood at $212.6 million in 2022, then slipped by 14.24% to $182.3 million in 2023, then climbed by 8.57% to $198.0 million in 2024, then jumped by 35.52% to $268.3 million in 2025, then increased by 0.87% to $270.6 million in 2026.
• Business Quant data shows WGS's Current Assets at $270.6 million in Q1 2026, $268.3 million in Q4 2025, and $237.6 million in Q3 2025.